ArticleTechnology in cancer research & treatment
Transformer-Based Deep Learning Model Using MRI-Derived Microvascular Atlas for Predicting Lymphovascular Invasion in Breast Cancer Patients.
Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IntroductionLymphovascular invasion (LVI), an aggressive pathological manifestation of breast cancer, is closely associated with increased risk of distant metastasis and poor prognosis. This study proposes a novel modeling strategy that integrates MRI-derived microvascular atlas parameters with the TwinsSVT deep learning architecture to enable noninvasive prediction of LVI status in breast cancer patients and to explore its biological interpretability.Materials and MethodsA total of 436 breast cancer patients from two medical centers, all pathologically confirmed postoperatively, were retrospectively enrolled. All patients underwent high-resolution multi-b-value diffusion-weighted imaging (DWI) prior to surgery. From the MRI data, four types of microvascular simulation parameter maps were reconstructed within tumor regions: apparent diffusion coefficient (ADC), mean flow velocity (v_m), velocity dispersion (v_s), and angiographic branching index (ANB), aiming to characterize intratumoral microcirculation and vascular structural complexity. These functional parametric maps were individually input into separate encoder branches of the TwinsSVT model to extract multi-scale spatial features. A multi-layer Transformer fusion module was then employed to capture structural interactions across modalities, thereby constructing a multi-parametric fusion model. Model performance was evaluated using metrics including area under the curve (AUC) and F1 score.ResultsCompared with single-parameter models, the multi-parametric fusion model demonstrated significantly improved predictive performance, with AUCs of 0.881 (95% CI: 0.781-0.982) and 0.859 (95% CI: 0.764-0.953) in internal and external validation cohorts, respectively. Grad-CAM visualizations revealed that the model predominantly focused on tumor margins and regions of high vascular density, suggesting a strong correlation between the model's attention and actual pathological structures.ConclusionThe deep learning model constructed based on MRI-derived microvascular simulation atlases enables noninvasive preoperative prediction of LVI status in breast cancer patients. By effectively capturing structural information and offering biological interpretability, the model holds promise as a robust imaging-based tool for precision subtyping and clinical decision support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.